Results 171 to 180 of about 5,580 (262)

A novel dual elastography-based model for screening high-risk varices in hepatitis B virus-related cirrhosis. [PDF]

Front Med (Lausanne)
Hu X, Chen M, Zheng Y, Yang X, Zhang W, Zhang Y, Yin Z, Liao J, Tang Y, Yu J, Liang P, Meng F.   +11 more
europepmc   +1 more source

Enhanced Liver Fibrosis Test, FIB-4 and FibroScan: Real-World Prognostic Accuracy for MASLD in a Biopsy-Controlled Cohort. [PDF]

Liver Int
Liguori A, D'Ambrosio F, Angelini G, Cefalo C, Galletti S, Cardinali S, Giustiniani MC, Marrone G, Biolato M, Rapaccini G, Pompili M, Grieco A, Mazza T, Urbani A, Sanguinetti M, Gasbarrini A, FPG‐UCSC PROMETEO‐ELF substudy Research Group, Miele L.   +17 more
europepmc   +1 more source

Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis. [PDF]

BMC Gastroenterol
Roy A, Jajodia S, Chakraborty S, Keyal S, Tewari A, Sonthalia N, Roy S, Khandelwal R, Kulkarni A, Ghoshal UC, Reddy R, Goenka MK.   +11 more
europepmc   +1 more source

When Support Meets Expectation: "The Negative Moderating Role of Transformational Leadership on Nurses' Intention to Stay". [PDF]

SAGE Open Nurs
Wang CK, Duong CH, Ho YH, Do DL, Dang QT, Hoang KTT.   +5 more
europepmc   +1 more source

[Interpretation of key updates of the 2026 version of the APASL clinical practice guidelines for the management of chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Liu HS, Ai XW, Sun YM, You H.
europepmc   +1 more source

A Novel Fibroblast Activation Protein-Based Algorithm to Assess Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

J Gastroenterol Hepatol
Wang ZV, Boumelhem BB, Pennell T, Bachovchin WW, Lai JH, Poplawski SE, Chandraratna H, Van Der Veken P, Brewer K, Leeming DJ, Ooi G, George J, Eslam M, Adams LA, Zhang HE, McCaughan GW, Majumdar A, Gorrell MD.   +17 more
europepmc   +1 more source

Noninvasive Tests for Predicting Decompensation in Compensated Advanced Chronic Liver Disease: A Comprehensive Review. [PDF]

Liver Int
Payancé A, Rautou PE, Boursier J, Castera L, Valla D, Elkrief L.   +5 more
europepmc   +1 more source

Nit

Aiguadolç, L', 1985
openaire   +1 more source

Reply to: "Are FIB-4 and liver stiffness measurement interchangeable for HCC risk stratification in MASLD?" [PDF]

JHEP Rep
Semmler G, Embacher J, Mandorfer M.
europepmc   +1 more source